Martin Burke, MD
Pain Medicine · Charleston, SCNPI 1053793588
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Abbott at 45.9% of the total.
Across 92 payments — averaging $123.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- MML US, Inc.$3K
- Medtronic$2K
- Nevro Corp.$610
- Boston Scientific$488
- Relievant Medsystems, Inc.$231
- plus $524 from 4 others
What the payments were for
- Travel & lodging$5,39448%
- Food & beverage$5,51449%
- Education$4204%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 23 | $5,195 |
| MML US, Inc. | 21 | $2,737 |
| Medtronic(2 entities) | 25 | $1,544 |
| Nevro Corp. | 10 | $610 |
| Boston Scientific | 6 | $488 |
| Relievant Medsystems, Inc. | 2 | $231 |
| SPR Therapeutics, Inc | 2 | $187 |
| Nalu Medical, Inc. | 1 | $184 |
| Globus Medical | 1 | $139 |
| EPI Health, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$4,126
- ReActiv8$1,814
- INTELLIS$420
- Proclaim Family of SCS IPGs$391
- ETERNA$389
- ACCOLADE SR$379
- Intracept$304
- Senza$271
- Senza Spinal Cord Stimulation System$267
- INTELLIS ADAPTIVESTIM$266
- SYNCHROMED$204
- Nalu Neurostimulation System$184
- SPRINT PNS System$132
How this compares
$11,328 in reported general payments places this provider in the 85th percentile of 92 pain medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 30 | $575 |
| Gabapentin | 69 | $566 |
| Diclofenac Sodium | 11 | $453 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $407 |
| Duloxetine Hcl | 34 | $357 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $163 |
| Mupirocin | 11 | $83 |
| Methocarbamol | 11 | $82 |
| Tramadol Hcl | 22 | $57 |
| Diazepam | 18 | $17 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Charleston
- Andrew MendelsonCharleston$19K
- Ameet NagpalCharleston$9K
- Justin WikleCharleston$5K
- Robert SullivanCharleston$5K
- Derrick RandallCharleston$3K
- Edward TavelCharleston$2K
- Michael HillegassCharleston$2K
- Meron SelassieCharleston$2K
- Ann FoxxCharleston$1K
- Phillip SmithGreenville$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.